Your browser doesn't support javascript.
loading
Pulmonary Delivery of Aerosolized Chloroquine and Hydroxychloroquine to Treat COVID-19: In Vitro Experimentation to Human Dosing Predictions.
Kolli, Aditya R; Semren, Tanja Zivkovic; Bovard, David; Majeed, Shoaib; van der Toorn, Marco; Scheuner, Sophie; Guy, Philippe A; Kuczaj, Arkadiusz; Mazurov, Anatoly; Frentzel, Stefan; Calvino-Martin, Florian; Ivanov, Nikolai V; O'Mullane, John; Peitsch, Manuel C; Hoeng, Julia.
Afiliação
  • Kolli AR; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Semren TZ; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Bovard D; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Majeed S; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • van der Toorn M; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Scheuner S; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Guy PA; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Kuczaj A; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Mazurov A; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Frentzel S; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Calvino-Martin F; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Ivanov NV; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • O'Mullane J; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Peitsch MC; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.
  • Hoeng J; PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. Julia.Hoeng@pmi.com.
AAPS J ; 24(1): 33, 2022 02 07.
Article em En | MEDLINE | ID: mdl-35132508
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloroquina / Tratamento Farmacológico da COVID-19 / Hidroxicloroquina / Modelos Químicos / Antimaláricos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloroquina / Tratamento Farmacológico da COVID-19 / Hidroxicloroquina / Modelos Químicos / Antimaláricos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article